Guida, F. Sun, N. Bantis, L.E. Muller, D.C. Li, P. Taguchi, A. Dhillon, D. Kundnani, D.L. Patel, N.J. Yan, Q. Byrnes, G. Moons, K.G.M. Tjønneland, A. Panico, S. Agnoli, C. Vineis, P. Palli, D. Bueno-De-Mesquita, B. Peeters, P.H. Agudo, A. Huerta, J.M. Dorronsoro, M. Barranco, M.R. Ardanaz, E. Travis, R.C. Byrne, K.S. Boeing, H. Steffen, A. Kaaks, R. Hüsing, A. Trichopoulou, A. Lagiou, P. La Vecchia, C. Severi, G. Boutron-Ruault, M.-C. Sandanger, T.M. Weiderpass, E. Nøst, T.H. Tsilidis, K. Riboli, E. Grankvist, K. Johansson, M. Goodman, G.E. Feng, Z. Brennan, P. Johansson, M. Hanash, S.M., Assessment of Lung Cancer Risk on the Basis of a Biomarker Panel of Circulating Proteins, JAMA Oncology, (4), 2018, American Medical Association, 2374-2437, 2374-2445